SEEL   $1.26  -48.57% Market Closed

Seelos Therapeutics Inc
Total Cash 294.00K
totalCashPerShare 0.79
EBITDA
Total Debt 10.16M
quickRatio 0.016
currentRatio 0.076
Total Revenue 2.01M
debtToEquity
Revenue/Share 23.168
ROA -2.61107
ROE
grossProfits
freeCashflow -34.28M
operatingCashflow -13.27M
earningsGrowth
revenueGrowth 0.119
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -8.3484
profitMargins 2.03128
enterpriseValue 10.34M
forwardPE
floatShares 370.48K
sharesOutstanding 581.00K
sharesShort 170.89K
sharesShortPriorMonth 25.34K
dateShortInterest
sharesPercentSharesOut 0.29%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.04%
Short Ratio help_outline 0.14%
shortPercentOfFloat 0.30%
impliedSharesOutstanding
bookValue -135.497
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon 4.09M
trailingEps 351.04%
forwardEps -1.31%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2024
institutionsCount 20
lastUpdated Oct. 16, 2024, 7:20 p.m.